The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...

Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the ...

According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

Researchers reviewed previously published studies to understand trends in multidrug-resistant treatment of TB in children and ...

An international trial identified three new, all-oral drug regimens for drug-resistant tuberculosis, improving treatment ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

One of the most significant challenges in cancer treatment is the development of drug resistance by cancer cells, which often ...

What is helping drive the increase of drug-resistant infections in Ukraine, why should the UK be on alert, and importantly, ...

While VNS can offer great relief, it is important to note that it does not cure epilepsy. The device helps manage seizures ...

A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC ...